Market Overview:
The global transcatheter aortic valve implantation (TAVI) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The TAVI market is segmented on the basis of type, application, and region. On the basis of type, the TAVI market is segmented into transfemoral approach, transapical approach, and others. The transfemoral approach segment dominates the global TAVI market in terms of revenue share in 2018 and is expected to maintain its dominance during the forecast period. On the basis of application, the TAVI market is divided into aortic stenosis, aortic regurgitation, and others. Geographically speaking North America leads with highest adoption rates for Transcatheter Aortaic Valve Implantations procedures followed by Europe due rising geriatric population base susceptible to heart diseases .
 Industry Outlook.svg)
Product Definition:
Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgical procedure used to replace a diseased or malfunctioning aortic valve. The replacement valve is delivered to the site of the defect through small incisions in the body, typically using transesophageal echocardiography (TEE) guidance. TAVI is an important treatment option for high-risk patients with severe aortic stenosis who are not candidates for traditional open heart surgery.
Transfemoral Approach:
The transfemoral approach is a surgical technique used to gain access to the heart via the femoral artery. The technique was first described by Cooley and Golden in 1924, who performed a cardiac catheterization from the femoral artery using an external stent. This procedure requires opening up of the abdomen and can be performed under local anesthesia or general anesthesia depending on patient’s condition.
Transapical Approach:
The transapical approach is a surgical technique used to implant aortic valve in the position between the two heart valves. This minimizes damage to blood vessels and reduces risk of infection. The number of patients who require this procedure is increasing due to growing prevalence of cardiovascular diseases, such as rheumatic heart disease, hypertension, and stroke.
Application Insights:
Aortic stenosis was the most prominent application segment in 2017 and is expected to grow at a lucrative CAGR during the forecast period. The high adoption rate of transcatheter valve in treating this condition is one of the key factors responsible for its dominance over other applications. According to data published by ESR, around 75% of patients with aortic stenosis are candidates for valve surgery; however, only 30-40% undergo open surgical procedures due to various risks associated with it.
The others segment includes moderate-to-severe valvular diseases that require urgent treatment but cannot be treated through conventional methods such as valves replacement or repair surgeries. Conventional transcatheter techniques cannot be used due to severe enough heart valve regurgitation or stenosis which requires immediate medical intervention and hence these conditions require alternative treatments such as TAVI procedures.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of aortic stenosis, increasing geriatric population, and favorable reimbursement policies & regulatory framework in this region. Moreover, an increase in awareness levels about TAVI and its benefits is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing target disease population base. Furthermore, economic development coupled with rising healthcare expenditure by governments for treating cardiovascular diseases is further expected to boost regional market growth during the forecast period (2018-2030). However, stringent government regulations regarding approval of new devices may pose a challenge for Transcatheter Aortic Valve Implantation (TAVI) device manufacturers/suppliers in some countries such as China & India which could affect overall revenue share over time.
Growth Factors:
- Increasing incidence of aortic stenosis: Aortic stenosis is a condition in which the aortic valve narrows and restricts blood flow from the left ventricle to the body. This condition is often associated with aging and can lead to heart failure if left untreated. The number of people affected by aortic stenosis is expected to increase in coming years due to the aging population, which will drive demand for TAVI procedures.
- Technological advancements: TAVI technology has continued to evolve over the past few years, with new devices being developed that are easier and less invasive to implant. This has helped make TAVI procedures more widely available and increased their adoption among patients at high risk for surgery.
- Growing awareness about TAVI: There is growing awareness among both physicians and patients about the benefits of TAVI procedures over traditional open heart surgery. As more studies are published on this topic, this trend is likely to continue, driving demand for TAVI procedures in the future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcatheter Aortic Valve Implantation (TAVI) Market Research Report
By Type
Transfemoral Approach, Transapical Approach, Others
By Application
Aortic Stenosis, Aortic Regurgitation, Others
By Companies
Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, Meril Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Transcatheter Aortic Valve Implantation (TAVI) Market Report Segments:
The global Transcatheter Aortic Valve Implantation (TAVI) market is segmented on the basis of:
Types
Transfemoral Approach, Transapical Approach, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Aortic Stenosis, Aortic Regurgitation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Edwards Lifesciences
- Medtronic
- St. Jude Medical
- Boston Scientific
- Meril Life Sciences
 Market Overview.svg)
Highlights of The Transcatheter Aortic Valve Implantation (TAVI) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transfemoral Approach
- Transapical Approach
- Others
- By Application:
- Aortic Stenosis
- Aortic Regurgitation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcatheter Aortic Valve Implantation (TAVI) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
TAVI is a surgical procedure that replaces an aortic valve with a mechanical or biologic device.
Some of the major companies in the transcatheter aortic valve implantation (tavi) market are Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, Meril Life Sciences.
The transcatheter aortic valve implantation (tavi) market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcatheter Aortic Valve Implantation (TAVI) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcatheter Aortic Valve Implantation (TAVI) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcatheter Aortic Valve Implantation (TAVI) Market - Supply Chain
4.5. Global Transcatheter Aortic Valve Implantation (TAVI) Market Forecast
4.5.1. Transcatheter Aortic Valve Implantation (TAVI) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcatheter Aortic Valve Implantation (TAVI) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transcatheter Aortic Valve Implantation (TAVI) Market Absolute $ Opportunity
5. Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Type
5.3.1. Transfemoral Approach
5.3.2. Transapical Approach
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Application
6.3.1. Aortic Stenosis
6.3.2. Aortic Regurgitation
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transcatheter Aortic Valve Implantation (TAVI) Demand Share Forecast, 2019-2026
9. North America Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Application
9.4.1. Aortic Stenosis
9.4.2. Aortic Regurgitation
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Type
9.7.1. Transfemoral Approach
9.7.2. Transapical Approach
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transcatheter Aortic Valve Implantation (TAVI) Demand Share Forecast, 2019-2026
10. Latin America Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Application
10.4.1. Aortic Stenosis
10.4.2. Aortic Regurgitation
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Type
10.7.1. Transfemoral Approach
10.7.2. Transapical Approach
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transcatheter Aortic Valve Implantation (TAVI) Demand Share Forecast, 2019-2026
11. Europe Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Application
11.4.1. Aortic Stenosis
11.4.2. Aortic Regurgitation
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transcatheter Aortic Valve Implantaton (TAVI) Market Size and Volume Forecast by Type
11.7.1. Transfemoral Approach
11.7.2. Transapical Approach
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transcatheter Aortic Valve Implantation (TAVI) Demand Share, 2019-2026
12. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Application
12.4.1. Aortic Stenosis
12.4.2. Aortic Regurgitation
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Type
12.7.1. Transfemoral Approach
12.7.2. Transapical Approach
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Demand Share, 2019-2026
13. Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Application
13.4.1. Aortic Stenosis
13.4.2. Aortic Regurgitation
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) Market Size and Volume Forecast by Type
13.7.1. Transfemoral Approach
13.7.2. Transapical Approach
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transcatheter Aortic Valve Implantation (TAVI) Market: Market Share Analysis
14.2. Transcatheter Aortic Valve Implantation (TAVI) Distributors and Customers
14.3. Transcatheter Aortic Valve Implantation (TAVI) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Edwards Lifesciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Meril Life Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
